Inspire Medical Systems, Inc. (INSP) vs Mineralys Therapeutics, Inc. (MLYS)
A side-by-side comparison of Inspire Medical Systems, Inc. and Mineralys Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INSP
Inspire Medical Systems, Inc.
$69.41HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
MLYS
Mineralys Therapeutics, Inc.
$22.81HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
Total return — INSP vs MLYS
growth of $100 · dividends reinvested · last 4yINSP -73.6% (-28.3%/yr)MLYS +26.4% (+6.0%/yr)MLYS compounded faster over this window
INSP MLYS
INSP vs MLYS: by the numbers
- •MLYS is the larger company ($2.01B vs $2.01B market cap).
- •INSP is profitable (15.03% net margin) while MLYS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | INSP | MLYS |
|---|---|---|
| P/E ratio | 15.02 | N/A |
| Forward P/E | 58.12 | N/A |
| P/S ratio | 2.23 | N/A |
| P/B ratio | 2.43 | 3.65 |
| EV / EBITDA | 26.75 | N/A |
| FCF yield | 5.84% | N/A |
Profitability
| Metric | INSP | MLYS |
|---|---|---|
| Gross margin | 86.13% | 0.00% |
| Operating margin | 6.02% | 0.00% |
| Net margin | 15.03% | 0.00% |
| ROE | 16.36% | -63.45% |
| ROIC | 6.33% | -57.17% |
Growth (annualized)
| Metric | INSP | MLYS |
|---|---|---|
| Revenue CAGR (5Y) | 38.69% | N/A |
| Total return CAGR (5Y) | -21.38% | N/A |
Frequently asked
- Is INSP or MLYS more profitable?
- INSP runs the higher net margin — INSP at 15.03% versus MLYS at 0.00%.
Go deeper
Dig into the metrics
Inspire Medical Systems P/E ratioInspire Medical Systems ROEMineralys Therapeutics ROEInspire Medical Systems operating marginMineralys Therapeutics operating marginInspire Medical Systems revenue growthMineralys Therapeutics revenue growthInspire Medical Systems free cash flowMineralys Therapeutics free cash flow
Inspire Medical Systems & Mineralys Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.